Key result
Angiotensin blockade with competitive antagonists of angiotensin II is discussed to evaluate the role of renin and angiotensin excess in the genesis of hypertension.
Answers are grounded in this paper and cite their sources.
This 1977 editorial discusses the emerging role of angiotensin blockade in understanding and managing renin-dependent hypertension.
Editorials1 March 1977Angiotensin Blockade in HypertensionDAVID H. P. STREETEN, M.B., D.PHIL., GUNNAR H. ANDERSON JR., M.D.DAVID H. P. STREETEN, M.B., D.PHIL.Search for more papers by this author, GUNNAR H. ANDERSON JR., M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-86-3-353 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptFor many years it has been known that plasma renin activity was elevated in some forms of human hypertension and that angiotensin II, the end-product of the reactions initiated by renin, could be the cause of such types of hypertension. Because the blood pressure has not always been raised when plasma renin activity was above normal, however, as in Bartter's syndrome or cirrhosis with ascites, it has been difficult to know what role, if any, was played by renin and angiotensin excess in the genesis of hypertension. The recent use of angiotensin blockade with competitive antagonists of angiotensin II, like...References1. BRUNNERGAVRASLARAGH HHJ: Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet 2:1045-1048, 1973 CrossrefMedlineGoogle Scholar2. STREETENANDERSONFREIBERG DGJ: Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension. N Engl J Med 292:657-662, 1975 CrossrefMedlineGoogle Scholar3. STREETENANDERSONDALAKOS DGT: Angiotensin blockade: its clinical significance. Am J Med 60:817-824, 1976 CrossrefMedlineGoogle Scholar4. GAVRASRIBEIROGAVRAS HAI: Reciprocal relation between renin dependency and sodium dependency in essential hypertension. N Engl J Med 295:1278-1283, 1976 CrossrefMedlineGoogle Scholar5. CASEWALLACEKEIM DJH: Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am J Med 61:790-796, 1976 CrossrefMedlineGoogle Scholar6. ANDERSONFREIBERGDALAKOS GJT: Effects of an angiotensin II analogue on hypertensive patients (abstract). Clin Res 22:628A, 1974 Google Scholar7. ANDERSONSTREETENDALAKOS GDT: Pressor response to 1-sar-8-ala-angiotensin II (saralasin) in hypertensive subjects. Circ Res, in press. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Section of Endocrinology Department of Medicine State University of New York Upstate Medical Center Syracuse, New York PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByHypertonie8 Renin in essential hypertension 1 March 1977Volume 86, Issue 3Page: 353-354KeywordsAscitesBlood pressureCirrhosisHypertensionPlasma renin activity Issue Published: 1 March 1977 PDF DownloadLoading ...
No takes yet. Share an insight, caveat, or question.
David H. P. Streeten (1977) conducted an editorial in Hypertension. Angiotensin blockade was evaluated. Angiotensin blockade with competitive antagonists of angiotensin II is discussed to evaluate the role of renin and angiotensin excess in the genesis of hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: